Cargando…
Ovarian cancer risk in premenopausal and perimenopausal women treated with Tamoxifen: a case–control study
As tamoxifen stimulates ovarian steroidogenesis in premenopausal women, induces ovulation and increases the incidence of benign ovarian cysts, there has been concern that it might also increase ovarian cancer risk in women treated premenopausally. In a national case–control study in Britain, treatme...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360088/ https://www.ncbi.nlm.nih.gov/pubmed/17285129 http://dx.doi.org/10.1038/sj.bjc.6603605 |